Aurora Cannabis (ACB) Stock Price, News & Analysis

Company Overview

Aurora Cannabis Inc. is a Canadian cannabis company focused primarily on the production, distribution and sale of medical cannabis. The company offers cannabis products such as dried flower, pre-rolls, oils, softgels, capsules and other formulations through its medical and consumer brands.

Founded in 2013 and headquartered in Edmonton, Alberta, Aurora serves adult-use and medical markets in Canada and supplies medical cannabis to selected international markets. Its international operations and partnerships have included markets in Europe, Australia and other regions where cannabis is permitted for medical use.

Aurora sells products under brands including Aurora, CanniMed, MedReleaf and San Rafael '71. The company is led by Chief Executive Officer Miguel Martin and is listed on the Nasdaq Capital Market under the symbol ACB.

Key Stats

• Today's Range: $4.29 to $4.55
• 50-Day Range: $2.81 to $4.59
• 52-Week Range: $2.56 to $6.36
• Volume: 593,586 shs
• Average Volume: 1.12 million shs
• Market Capitalization: $285.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Aurora Cannabis Stock Analysis - MarketRank™

Aurora Cannabis scored higher than 22% of companies evaluated by MarketBeat, and ranked 812th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.6 / 5
• Analyst Rating: Hold

Consensus Rating

Aurora Cannabis has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Aurora Cannabis has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Aurora Cannabis are expected to grow in the coming year, from ($0.07) to $0.06 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aurora Cannabis is -3.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aurora Cannabis is -3.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Aurora Cannabis has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

11.63% of the float of Aurora Cannabis has been sold short.

Short Interest Ratio / Days to Cover

Aurora Cannabis has a short interest ratio ("days to cover") of 9.45.

Change versus previous month

Short interest in Aurora Cannabis has recently increased by 2.68%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aurora Cannabis does not currently pay a dividend.

Dividend Growth

Aurora Cannabis does not have a long track record of dividend growth.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.27

News Sentiment

Aurora Cannabis has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Aurora Cannabis this week, compared to 4 articles on an average week.

Search Interest

3 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

MarketBeat Follows

14 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.01% of the stock of Aurora Cannabis is held by insiders.

Percentage Held by Institutions

47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/12/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:ACB
• Previous Symbol: NYSE:ACB
• CIK: 1683541
• Web: auroramj.com
• Phone: (604) 362-5207
• Fax: N/A
• Employees: 1,028
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): ($1.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$88.13 million
• Net Margins: -32.26%
• Pretax Margin: -11.84%
• Return on Equity: 4.37%
• Return on Assets: 3.45%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 5.36
• Quick Ratio: 2.80

Sales & Book Value

• Annual Sales: $247.82 million
• Price / Sales: 1.15
• Cash Flow: $0.68 per share
• Price / Cash Flow: 6.40
• Book Value: $6.27 per share
• Price / Book: 0.69

Miscellaneous

• Outstanding Shares: 65,720,000
• Free Float: 65,717,000
• Market Cap: $285.88 million
• Optionable: Optionable
• Beta: 0.63